Thalidomide-5,6-F 是一种基于 Thalidomide 的，可募集 CRBN 蛋白的 cereblon 配体。Thalidomide-5,6-F 可通过 linker 与靶蛋白配体连接，形成 PROTAC 分子。
Thalidomide-5,6-F is the Thalidomide-based cereblon ligand used in the recruitment of CRBN protein. Thalidomide-5,6-F can be connected to the ligand for protein by a linker to form PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].
[1]. Liu K, et al. Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma. Org Biomol Chem. 2013;11(29):4757-4763.
动态评分
0.0